A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer



Status:Archived
Conditions:Cancer, Cancer, Pancreatic Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:May 2010
End Date:June 2013

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Study Evaluating Safety and Efficacy of Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Adenocarcinoma


The purpose of this study is to find out the effects, good and/or bad, of the combination of
two drugs, gemcitabine and bosutinib, in patients with resected pancreatic cancer and
whether this combination can prevent pancreatic cancer from coming back.



We found this trial at
2
sites
UCSF Helen Diller Family Comprehensive Cancer Center
1600 Divisadero Street
San Francisco, California 94115
888.689.8273
UCSF Helen Diller Family Comprehensive Cancer Center UCSF’s long tradition of excellence in cancer research...
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
Huntsman Cancer Hospital
Salt Lake City, Utah 84112
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials